The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes
Authors:
Open Access
- 24 September 2024
- journal article
- review article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (9) , 348
Abstract
Arrhythmogenic cardiomyopathy (ACM) is a cardiac disease featured by non-ischemic myocardial scarring linked to ventricular electrical instability. As there is no single gold-standard test, diagnosing ACM remains challenging and a combination of specific criteria is needed. The diagnostic criteria were first defined and widespread in 1994 and then revised in 2010, approaching and focusing primarily on right ventricular involvement without considering any kind of left ventricular variant or phenotype. Years later, in 2020, with the purpose of overcoming previous limitations, the Padua Criteria were introduced by an international expert report. The main novel elements were the introduction of specific criteria for left ventricular variants as well as the use of cardiac magnetic resonance for tissue characterization and scar detection. The last modifications and refinement of these criteria were published at the end of 2023 as the European Task Force criteria, by a “head-quarter” of ACM international experts, proving the emerging relevance of this condition besides its difficult diagnosis. In this review, emphasizing the progress in understanding the aetiology of the cardiomyopathy, an analysis of the new criteria is presented. The introduction of the term “scarring/arrhythmogenic cardiomyopathy” sets an important milestone in this field, underlying how non-ischemic myocardial scarring—typical of ACM—and arrhythmic susceptibility could be the main pillars of numerous different phenotypic variants regardless of etiology.Keywords
This publication has 44 references indexed in Scilit:
- Diagnosing isolated cardiac sarcoidosisJournal of Internal Medicine, 2011
- Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force CriteriaEuropean Heart Journal, 2010
- Left-Dominant Arrhythmogenic CardiomyopathyJACC, 2008
- Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation, 2006
- Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axisHeart Rhythm, 2006
- Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of CardiomyopathiesCirculation, 1996
- Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.Heart, 1994
- Right Ventricular Cardiomyopathy: Another Cause of Sudden Death in the YoungNew England Journal of Medicine, 1988
- Right Ventricular Cardiomyopathy and Sudden Death in Young PeopleNew England Journal of Medicine, 1988
- Right ventricular dysplasia: a report of 24 adult cases.Circulation, 1982